128 related articles for article (PubMed ID: 4875710)
1. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
2. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
3. Studies on the mechanism of xylitol-induced insulin secretion in dogs. Effect of its infusion into the pancreatic artery, and the inhibition by epinephrine and diazoxide of xylitol-induced hyperinsulinaemia.
Kuzuya T; Kanazawa Y
Diabetologia; 1969 Aug; 5(4):248-57. PubMed ID: 4902720
[No Abstract] [Full Text] [Related]
4. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
5. AO44: an improved hyperglycemic agent.
Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
[No Abstract] [Full Text] [Related]
6. Effect of thiazides upon insulin secretion in vitro.
Malaisse W; Malaisse-Legae F
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):235-9. PubMed ID: 4868989
[No Abstract] [Full Text] [Related]
7. [Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
Frerichs H; Gerber R; Creutzfeldt W
Diabetologia; 1966 Dec; 2(4):269-76. PubMed ID: 4902707
[No Abstract] [Full Text] [Related]
8. The morphological substrate of the inhibition of insulin secretion by diazoxide.
Creutzfeldt W; Creutzfeldt C; Frerichs H; Perings E; Sicklinger K
Horm Metab Res; 1969 Mar; 1(2):53-64. PubMed ID: 4334867
[No Abstract] [Full Text] [Related]
9. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
10. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
11. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
[No Abstract] [Full Text] [Related]
12. [The effect of diazoxide on glucagon-induced insulin secretion].
Brech WJ; Kaess H; Schlierf G; Rohs M
Klin Wochenschr; 1968 Apr; 46(8):449-50. PubMed ID: 4879594
[No Abstract] [Full Text] [Related]
13. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
Mariot P; Gilon P; Nenquin M; Henquin JC
Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
[TBL] [Abstract][Full Text] [Related]
14. [Studies on the effect of various sulfonylureas during adrenergic blockade of the insulin secretion in man].
Haslbeck M; Brauch K; Hepp KD; Mehnert H
Verh Dtsch Ges Inn Med; 1971; 77():543-6. PubMed ID: 5005529
[No Abstract] [Full Text] [Related]
15. Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide.
Anderson JH; Byrd GW; Blackard WG
Metabolism; 1971 Nov; 20(11):1023-30. PubMed ID: 4329940
[No Abstract] [Full Text] [Related]
16. Factors controlling release of insulin from beta cell in relation to diabetes mellitus.
Romanoff NE
N Y State J Med; 1968 Feb; 68(3):385-91. PubMed ID: 4865846
[No Abstract] [Full Text] [Related]
17. [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Chapal J
Diabetologia; 1969 Feb; 5(1):1-10. PubMed ID: 4907149
[No Abstract] [Full Text] [Related]
18. [Morphology and histochemistry of insulin secretion].
Creutzfelt W
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():387-416. PubMed ID: 4313827
[No Abstract] [Full Text] [Related]
19. Experimental and clinical studies with diazoxide.
Wolff F; Hirsch E; Wales J; Viktora J
Ann N Y Acad Sci; 1968 Apr; 150(2):429-41. PubMed ID: 4875711
[No Abstract] [Full Text] [Related]
20. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
[No Abstract] [Full Text] [Related]
[Next] [New Search]